Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Vet Dermatol ; 24(1): 212-7.e46-7, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23331700

ABSTRACT

BACKGROUND: Pituitary pars intermedia dysfunction (PPID) in older equids is commonly recognized by a long hair coat that fails to shed. OBJECTIVE: The aim of this study was to compare hair follicle stages in PPID-affected horses with excessively long hair coats with the stages of normal aged horses (controls) and to compare hair follicle stages in PPID-affected horses after 6 months of treatment with pergolide mesylate with those of control horses. ANIMALS: Eight PPID-affected horses and four normal, age-matched, control horses. METHODS: Skin biopsies were collected from the neck and rump of PPID-affected and control horses. A diagnosis of PPID was established based on hair coat changes and supportive overnight dexamethasone suppression test results. Skin biopsies were repeated after 6 months of treatment with pergolide. The number of hair follicles in anagen (A) or telogen (T) was counted for each skin biopsy using transverse sections. RESULTS: Pretreatment biopsies had a greater percentage of A follicles (neck 96%, rump 95%) and a lower percentage of T follicles (neck 4%, rump 5%) in PPID-affected horses than in control horses (A, neck 15%, rump 25%; and T, neck 85%, rump 75%). After treatment with pergolide, all PPID-affected horses had improved shedding, and the percentages of A follicles (neck 69%, rump 70%) and T follicles (neck 31%, rump 30%) were not different from untreated control horses (A, neck 68%, rump 82%; and T, neck 32%, rump 18%). CONCLUSIONS: These findings document that excessive hair growth (hypertrichosis) in PPID-affected horses is due to persistence of hair follicles in A. Furthermore, treatment with pergolide improved shedding and reduced the percentage of A follicles in PPID-affected horses.


Subject(s)
Hair Follicle/pathology , Hair/growth & development , Horse Diseases/metabolism , Pituitary Diseases/veterinary , Pituitary Gland, Intermediate , Aging , Animals , Dopamine Agonists/therapeutic use , Female , Horses , Male , Pergolide/therapeutic use , Pituitary Diseases/drug therapy , Pituitary Diseases/pathology
2.
Vet Clin North Am Small Anim Pract ; 43(1): 113-34, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23182328

ABSTRACT

Cutaneous vasculitis is an inflammatory process targeting blood vessels. Underlying factors include drugs, infectious diseases, adverse reactions to food, malignancies, and immune-mediated diseases. Vasculitis is a reaction pattern warranting a workup to identify triggers. Presenting symptoms include purpura, pitting edema, and skin ulcerations. Constitutional signs include fever, depression, and anorexia and seem to be present in the majority of patients. Once a diagnosis is confirmed, treatment and follow-up must be tailored to the individual. High-dose immunosuppressive medications are only recommended once infectious diseases capable of producing a similar constellation of clinical signs have been ruled out.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Immunosuppressive Agents/therapeutic use , Skin Diseases, Vascular/veterinary , Skin/blood supply , Animals , Blood Vessels/immunology , Blood Vessels/pathology , Cat Diseases/chemically induced , Cat Diseases/diagnosis , Cat Diseases/drug therapy , Cats , Diagnosis, Differential , Dog Diseases/chemically induced , Dog Diseases/diagnosis , Dog Diseases/drug therapy , Dogs , Skin/immunology , Skin/pathology , Skin Diseases, Vascular/chemically induced , Skin Diseases, Vascular/diagnosis , Skin Diseases, Vascular/drug therapy , Vasculitis/chemically induced , Vasculitis/diagnosis , Vasculitis/drug therapy , Vasculitis/veterinary , Veterinary Drugs/adverse effects , Veterinary Drugs/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...